MIF "Rediscovered"

MIF: Most Interesting Factor

Volumn , Issue , 2007, Pages 19-34

  Bucala, Richard ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84969277846     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9789812775917_0002     Document Type: Chapter

References (68)

1. Rich AR, Lewis MR. (1932) The nature of allergy in tuberculosis as revealed by tissue culture studies. Bulletin of The Johns Hopkins Hospital 50:115-131.
2. Weiser WY, Temple PA, Witek-Giannotti JS, et al. (1989) Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor. Proc Natl Acad Sci USA 86: 7522-7526.
3. Bernhagen J, Mitchell RA, Calandra T, et al. (1994) Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). Biochemistry 33: 14144-14155.
4. Hermanowski-Vosatka A, Mundt SS, Ayala JM, et al. (1999) Enzymatically inactive macrophage migration inhibitory factor inhibits monocyte chemotaxis and random migration. Biochemistry 38: 12841-12949.
5. Rhen T, Cidlowski JA, (2005) Antiinflammatory action of glucocorticoids - new mechanisms for old drugs. New Engl J Med 353: 1711-1723.
6. Bucala R. (1996) MIF rediscovered: cytokine, pituitary hormone, and glucocorticoid-induced regulator of the immune response. FASEB J 10:1607-1613.
7. Bernhagen J, Calandra T, Mitchell RA, et al. (1993) MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 365: 756-759.
8. Calandra T, Bernhagen J, Metz CN, et al. (1995) MIF as a glucocorticoidinduced modulator of cytokine production. Nature 377: 68-71.
9. Calandra T, Bernhagen J, Mitchell RA, Bucala R. (1994) The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 179: 1895-1902.
10. Calandra T, Spiegel LA, Metz CN, Bucala R. (1998) Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of Gram-positive bacteria. Proc Natl Acad Sci USA 95:11383-11388.
11. Bernhagen J, Bacher M, Calandra T, et al. (1996) An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction. J Exp Med 183: 277-282.
12. Martiney JA, Sherry B, Metz CN, et al. (2000) Macrophage migration inhibitory factor release by macrophages after ingestion of Plasmodium chabaudi-infected erythrocytes: possible role in the pathogenesis of malarial anemia. Infect Immun 68: 2259-2267.
13. Bozza M, Satoskar AR, Lin G, et al. (1999) Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J Exp Med 189:341-346.
14. Mitchell RA, Liao H, Chesney J, et al. (2002) Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc Natl Acad Sci USA 99: 345-350.
15. Bacher M, Metz CN, Calandra T, et al. (1996) An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci USA 93: 7849-7854.
16. Benigni F, Atsumi T, Calandra T, et al. (2000) The proinflammatory mediator macrophage migration inhibitory factor (MIF) induces glucose catabolism in muscle. J Clin Invest 106: 1291-1300.
17. Bacher M, Meinhardt A, Lan HY, et al. (1997) Migration inhibitory factor expression in experimentally induced endotoxemia. Am J Pathol 150:235-246.
18. Fingerle-Rowson G, Koch P, Bikoff R, et al. (2003) Regulation of macrophage migration inhibitory factor expression by glucocorticoids in vivo. Am J Pathol 162: 47-56.
19. Feldmann M, Brennan FM, Paleolog E, et al. (2004) Anti-TNFα therapy of rheumatoid arthritis: what can we learn about chronic disease? Novartis Found Symp 256: 53-69.
20. Donnelly SC, Haslett C, Reid PT, et al. (1997) Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nature Med 3: 320-323.
21. de Jong YP, Abadia-Molina AC, Satoskar AR, et al. (2001) Development of chronic colitis is dependent on the cytokine MIF. Nat. Immunol 2:1061-1066.
22. Onodera S, Kaneda K, Mizue Y, et al. (2000) Macrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arthritis. J Biol Chem 275: 444-450.
23. Onodera S, Nishihira J, Iwabuchi K, et al. (2002) Macrophage migration inhibitory factor up-regulates matrix metalloproteinase-9 and -13 in rat osteoblasts Relevance to intracellular signaling pathways. J Biol Chem 277:7865-7874.
24. Sampey AV, Hall PH, Mitchell RA, et al. (2001) Regulation of synoviocyte phospholipase A2 and cyclooxygenase 2 by macrophage migration inhibitory factor. Arthritis Rheum 44: 1273-1280.
25. Suzuki M, Sugimoto H, Nakagawa A, et al. (1996) Crystal structure of the macrophage migration inhibitory factor from rat liver. Nature Struct Biol 3:259-66.
26. Sun HW, Bernhagen J, Bucala R, Lolis E. (1996) Crystal structure at 26-A resolution of human macrophage migration inhibitory factor. Proc Natl Acad Sci USA 93: 5191-5196.
27. Kato Y, Muto T, Tomura T, et al. (1996) The crystal structure of human glycosylation-inhibiting factor is a trimeric barrel with three 6-stranded betasheets. Proc Natl Acad Sci USA 93: 3007-10.
28. Leng L, Metz C, Fang Y, et al. (2003) MIF signal transduction initiated by binding to CD74. J Exp Med 197: 1467-1476.
29. Mitchell RA, Metz CN, Peng T, Bucala R. (1999) Sustained mitogenactivated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF). Regulatory role in cell proliferation and glucocorticoid action. J Biol Chem 274: 18100-18106.
30. Roger T, Chanson AL, Knaup-Reymond M, Calandra T. (2005) Macrophage migration inhibitory factor promotes innate immune responses by suppressing glucocorticoid-induced expression of mitogen-activated protein kinase phosphatase-1. Eur J Immunol 35: 3405-3413.
31. Kleemann R, Hausser A, Geiger G, Mischke R, et al. (2000) Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature 408: 211-216.
32. Hudson JD, Shoaibi MA, Maestro R, et al. (1999) A proinflammatory cytokine inhibits p53 tumor suppressor activity. J Exp Med 190: 1375-1382.
33. Fingerle-Rowson G, Satoskar A, Bucala R. (2003) Macrophage migration inhibitory factor (MIF)-deficient mice. In: G Fantuzzi (ed.) Cytokine Knockouts, Humana Press Totowa, NJ, pp. 361-378.
34. Rosengren E, Bucala R, Aman P, et al. (1996) The immunoregulatory mediator macrophage migration inhibitory factor (MIF) catalyzes a tautomerization reaction. Molecul Med 2: 143-149.
35. Infanger LC, Rocheleau TA, Bartholomay LC, et al. (2004) The role of phenylalanine hydroxylase in melanotic encapsulation of filarial worms in two species of mosquitoes. Insect Biochem Molecul Biol 34: 1329-1338.
36. Stamps SL, Fitzgerald MC, Whitman CP. (1998) Characterization of the role of the amino-terminal proline in the enzymatic activity catalyzed by macrophage migration inhibitory factor. Biochemistry 37: 10195-10202.
37. Swope MD, Lolis E. (1999) Macrophage migration inhibitory factor: cytokine hormone or enzyme. Rev Physiol Biochem Pharmacol 139: 1-32.
38. Bendrat K, Al-Abed Y, Callaway DJ, et al. (1997) Biochemical and mutational investigations of the enzymatic activity of macrophage migration inhibitory factor. Biochemistry 36: 15356-15362.
39. Taylor AB, Johnson WH, Czerwinski RM, et al. (1998) Crystal structure of macrophage migration inhibitory factor complexed with (E)-2-fluoro-phydroxycinnamate at 1.8 A resolution: implications for enzymatic catalysis and inhibition. Biochemistry 38: 7444-7454.
40. Swope M, Sun HW, Blake PR, Lolis E (1998) Direct link between cytokine activity and a catalytic site for macrophage migration inhibitory factor. EMBO J 17: 3534-3541.
41. Senter PD, Al-Abed Y, Metz CN, et al. (2002) Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites. Proc Natl Acad Sci USA 99: 144-149.
42. Lolis E, Bucala R. (2003) Macrophage migration inhibitory factor. Expert Opin Therap Targets 7: 153-164.
43. Baugh JA, Chitnis S, Donnelly SC, et al. (2002) A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun 3:170-176.
44. Fingerle-Rowson GR, Bucala R. (2001) Neuroendocrine properties of macrophage migration inhibitory factor (MIF). Immunol Cell Biol 79:368-375.
45. Donn RP, Shelley E, Ollier WE, Thomson W. (2001) A novel 5_-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 44:1782-1785.
46. De Benedetti F, Meazza C, Vivarelli M, et al. (2003) Functional and prognostic relevance of the -173 polymorphism of the MIF gene in systemic juvenile idiopathic arthritis. Arthritis Rheum 48: 1398-1407.
47. Donn R, Alourfi Z, Zeggini E, et al. (2004) A functional promoter haplotype of macrophage migration inhibitory factor is linked and associated with juvenile idiopathic arthritis. Arthritis Rheum. 50: 1604-1610.
48. Plant BJ, Gallagher CG, Bucala R, et al. (2005) Cystic fibrosis disease severity and a macrophage migration inhibitory factor polymorphism. Am J Respir Crit Care Med 172: 1412-1415.
49. Mizue Y, Ghani S, Leng L, et al. (2005) Role for macrophage migration inhibitory factor (MIF) in asthma. Proc Natl Acad Sci USA 102:14410-14415.
50. Gregersen P, Bucala R. (2003) MIF Mif alleles, and the genetics of inflammatory disorders: incorporating disease outcome into the definition of phenotype. Arthritis Rheum 48: 1171-1176.
51. Amoli M, Donn R, Thomson W, et al. (2002) Macrophage migration inhibitory factor gene polymorphism is associated with sarcoidosis in biopsy proven erythema nodosum, J Rheumatol 29: 1671-1673.
52. Radstake TRDJ, Sweep FCGJ, Welsing P, et al. (2005) Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor. Arthritis Rheum 52:3020-3029.
53. Wu S-P, Leng L, Feng Z, et al. (2006) MIF promoter polymorphisms influence the clinical expression of scleroderma. Arthritis Rheum 54: 3661-3669.
54. Calandra T, Roger T. (2003) Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 3: 791-800.
55. Donn RP, Ray DW. (2004) Macrophage migration inhibitory factor: molecular, cellular and genetic aspects of a key neuroendocrine molecule. J Endocrinol 182: 1-9.
56. Nohara H, Okayam N, Inoue N, et al. (2004) Association of the -173G/C polymorphism of the macrophage migration inhibitory factor gene with ulcerative colitis. J Gastroenterol 39: 242-246.
57. Hizawa N, Yamaguchi E, Takahashi D, et al. (2004) Functional polymorphisms in the promoter region of macrophage migration inhibitory factor and atopy. Am J Resp Crit Care Med 169: 1014-1018.
58. Calandra T, Echtenacher B, Le Roy D, et al. (2000) Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nature Med. 6: 164-169.
59. Koebernick H, Grode L, David JR, et al. (2002), Macrophage migration inhibitory factor (MIF) plays a pivotal role in immunity against Salmonella typhimuriumi. Proc Nat Acad Sci USA 99: 13681-13686.
60. Rodriguez-Sosa M, Rosas LE, David JR, et al. (2003) Macrophage migration inhibitory factor plays a critical role in mediating protection against the helminth parasite Taenia crassiceps. Infect Immun 71: 1247-1254.
61. McDevitt MA, Xie J, Shanmugasundaram G, et al. (2006) A critical role for the host mediator macrophage migration inhibitory factor in the pathogenesis of malarial anemia. J Exp Med 203: 1185-1196.
62. Satoskar A, Bozza M, Rodriguez Sosa M, et al. (2001) Migration inhibitory factor gene-deficient mice are susceptible to cutaneous Leishmania major infection. Infect Immun 69: 906-911.
63. Janeway CA, Travers P, Walport M, Shlomchik M. (2005) Antigen presentation to T lymphocytes. In: Immunobiology, pp.169-201, Garland, New York.
64. Chaisanvaneeyakorn S, Moore J, Othoro C, et al. (2002) Immunity to placental malaria. IV. Placental malaria is associated with up-regulation of macrophage migration inhibitory factor in intervillous blood. J Infect Dis 186: 1371-1375.
65. Zhong XB, Leng L, Beitin A, et al. (2005) Simultaneous detection of microsatellite repeats and SNPs in the macrophage migration inhibitory factor (MIF) gene by thin-film biosensor chips and application to rural field studies. Nucl Acids Res 33.
66. Stevenson MM, Riley EM. (2004) Innate immunity to malaria. Nature Rev. Immuno. 4: 169-180.
67. McDevitt M, Xie J, Gordeuk V, Bucala R. (2004) The anemia of malaria infection: role of inflammatory cytokines. Curr Hematol Rep 3: 97-106.
68. Cooke GS, Hill AV. (2001) Genetics of susceptibility to human infectious disease. Nat Rev Genet 2: 967-977.